{"id":"https://openalex.org/W4388564355","doi":"https://doi.org/10.1136/jitc-2023-007697","title":"Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer","display_name":"Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4388564355","doi":"https://doi.org/10.1136/jitc-2023-007697","pmid":"https://pubmed.ncbi.nlm.nih.gov/37949617","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10649798"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-007697","doi":"https://doi.org/10.1136/jitc-2023-007697","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007697","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2023-007697","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059138103","display_name":"Els M.E. Verdegaal","orcid":"https://orcid.org/0000-0002-4449-8707","observed_orcids":["https://orcid.org/0000-0002-4449-8707"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Els M E Verdegaal","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-4449-8707","affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032553128","display_name":"Saskia J A M Santegoets","orcid":"https://orcid.org/0000-0002-2874-4402","observed_orcids":["https://orcid.org/0000-0002-2874-4402"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Saskia J Santegoets","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-2874-4402","affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069267169","display_name":"Marij J.P. Welters","orcid":"https://orcid.org/0000-0002-9809-8266","observed_orcids":["https://orcid.org/0000-0002-9809-8266"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marij J P Welters","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050294061","display_name":"Linda de Bruin","orcid":"https://orcid.org/0009-0001-5296-7542","observed_orcids":["https://orcid.org/0009-0001-5296-7542"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Linda de Bruin","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078026201","display_name":"Marten Visser","orcid":"https://orcid.org/0000-0002-8544-131X","observed_orcids":["https://orcid.org/0000-0002-8544-131X"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marten Visser","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023896452","display_name":"Caroline E. van der Minne","orcid":"https://orcid.org/0009-0004-8345-2009","observed_orcids":["https://orcid.org/0009-0004-8345-2009"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Caroline E van der Minne","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091763395","display_name":"Pita de Kok","orcid":"https://orcid.org/0009-0009-6781-6884","observed_orcids":["https://orcid.org/0009-0009-6781-6884"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Pita M de Kok","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059027820","display_name":"Nikki M. Loof","orcid":"https://orcid.org/0009-0008-5642-8627","observed_orcids":["https://orcid.org/0009-0008-5642-8627"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Nikki M Loof","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031418806","display_name":"Sanne Boekestijn","orcid":"https://orcid.org/0000-0003-2191-7689","observed_orcids":["https://orcid.org/0000-0003-2191-7689"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sanne Boekestijn","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041980286","display_name":"Inge C.F.M. Roozen","orcid":"https://orcid.org/0009-0006-1352-5684","observed_orcids":["https://orcid.org/0009-0006-1352-5684"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Inge Roozen","raw_affiliation_strings":["Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113777303","display_name":"Inge M. Westra","orcid":"https://orcid.org/0009-0009-3271-495X","observed_orcids":["https://orcid.org/0009-0009-3271-495X"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Inge M Westra","raw_affiliation_strings":["Center for Cell and Gene Therapy, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059973952","display_name":"Pauline Meij","orcid":"https://orcid.org/0000-0003-3370-9932","observed_orcids":["https://orcid.org/0000-0003-3370-9932"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Pauline Meij","raw_affiliation_strings":["Center for Cell and Gene Therapy, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041281028","display_name":"Sjoerd H. van der Burg","orcid":"https://orcid.org/0000-0002-6556-0354","observed_orcids":["https://orcid.org/0000-0002-6556-0354"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sjoerd H Van der Burg","raw_affiliation_strings":["Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-6556-0354","affiliations":[{"raw_affiliation_string":"Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021122880","display_name":"Judith R. Kroep","orcid":"https://orcid.org/0000-0003-2671-1903","observed_orcids":["https://orcid.org/0000-0003-2671-1903"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Judith R Kroep","raw_affiliation_strings":["Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0003-2671-1903","affiliations":[{"raw_affiliation_string":"Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5059138103"],"corresponding_institution_ids":["https://openalex.org/I2800006345"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":3.7976,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.95261649,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"11","issue":"11","first_page":"e007697","last_page":"e007697"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.37209999561309814,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.37209999561309814,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.28369998931884766,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.10480000078678131,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.996999979019165},{"id":"https://openalex.org/keywords/recurrent-epithelial-ovarian-cancer","display_name":"recurrent epithelial ovarian cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/platinum-sensitive-ovarian-cancer","display_name":"platinum-sensitive ovarian cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8550000190734863},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9819999933242798},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.9610000252723694},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8700000047683716},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8479999899864197},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8859999775886536},{"id":"https://openalex.org/keywords/platinum-free-interval","display_name":"platinum-free interval","score":0.6150000095367432},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.5130000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7891421318054199},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.6744565963745117},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6405460238456726},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5684628486633301},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5437504053115845},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5135707855224609},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4971936047077179},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.4575693905353546},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4244716465473175},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40451687574386597},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.39136940240859985},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36483633518218994},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3482130169868469}],"mesh":[{"descriptor_ui":"D000077216","descriptor_name":"Carcinoma, Ovarian Epithelial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010984","descriptor_name":"Platinum","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1136/jitc-2023-007697","doi":"https://doi.org/10.1136/jitc-2023-007697","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007697","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10649798","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10649798","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10649798/pdf/jitc-2023-007697.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:37949617","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37949617","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:alma.31UKB_LEU:9940750406402711","doi":null,"is_oa":true,"landing_page_url":"https://scholarlypublications.universiteitleiden.nl/handle/1887/3736255","pdf_url":"https://scholarlypublications.universiteitleiden.nl/download/1887/3736255/1?col=81522199720002711","source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, No. 11","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:scholarlypublications.universiteitleiden.nl:item_3736255","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1887/3736255","pdf_url":"https://jitc.bmj.com/content/jitc/11/11/e007697.full.pdf","source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:doaj.org/article:23ac6018768843a28d87a7fb513a2cca","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/23ac6018768843a28d87a7fb513a2cca","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-007697","doi":"https://doi.org/10.1136/jitc-2023-007697","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007697","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1650945856","display_name":null,"funder_award_id":"2021-13673","funder_id":"https://openalex.org/F4320322777","funder_display_name":"KWF Kankerbestrijding"}],"funders":[{"id":"https://openalex.org/F4320317535","display_name":"Ovacure Foundation","ror":"https://ror.org/03vz29v35"},{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388564355.pdf","grobid_xml":"https://content.openalex.org/works/W4388564355.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1487631743","https://openalex.org/W1857903828","https://openalex.org/W1976044621","https://openalex.org/W1986718396","https://openalex.org/W2027726380","https://openalex.org/W2030191482","https://openalex.org/W2036159305","https://openalex.org/W2126333580","https://openalex.org/W2127734125","https://openalex.org/W2132923173","https://openalex.org/W2134069241","https://openalex.org/W2137074525","https://openalex.org/W2138035969","https://openalex.org/W2143778531","https://openalex.org/W2148523692","https://openalex.org/W2150678612","https://openalex.org/W2151050516","https://openalex.org/W2151246207","https://openalex.org/W2161101420","https://openalex.org/W2162184613","https://openalex.org/W2163825610","https://openalex.org/W2169729679","https://openalex.org/W2313517337","https://openalex.org/W2329342162","https://openalex.org/W2338563218","https://openalex.org/W2556817416","https://openalex.org/W2742440809","https://openalex.org/W2772497653","https://openalex.org/W2794196642","https://openalex.org/W2801187712","https://openalex.org/W2894424410","https://openalex.org/W3012160408","https://openalex.org/W3014244632","https://openalex.org/W3185825827","https://openalex.org/W3193095160","https://openalex.org/W4240735601","https://openalex.org/W4295078726","https://openalex.org/W4322492208","https://openalex.org/W4382751473"],"related_works":["https://openalex.org/W3213398422","https://openalex.org/W4388495181","https://openalex.org/W3203736331","https://openalex.org/W4415871433","https://openalex.org/W2396404964","https://openalex.org/W2163825610","https://openalex.org/W2761676127","https://openalex.org/W1857903828","https://openalex.org/W2894424410","https://openalex.org/W1593456789"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,116,302],"presence":[2],"of":[3,61,139,182,213,244,283,319],"T":[4,64],"cells":[5,9,45],"and":[6,18,46,95,112,124,131,135,199,205,218,232,272,307],"suppressive":[7],"myeloid":[8,215],"in":[10,75,102,211,239,265,275,298,305,310],"epithelial":[11],"ovarian":[12],"cancer":[13],"(EOC)":[14],"correlate":[15],"with":[16,34,77,105,172,179,194,280,293,300],"good":[17],"bad":[19],"clinical":[20,133,204],"outcome,":[21],"respectively.":[22],"This":[23],"suggests":[24],"that":[25,40,257,278],"EOC":[26,80,338],"may":[27],"be":[28,154,290],"sensitive":[29],"to":[30,120,127,175],"adoptive":[31],"cell":[32,216],"therapy":[33,288],"autologous":[35],"tumor-infiltrating":[36],"lymphocytes":[37],"(TIL),":[38],"provided":[39],"immunosuppression":[41,306],"by":[42],"myeloid-derived":[43],"suppressor":[44],"M2":[47],"macrophages":[48],"is":[49],"reduced.":[50],"Platinum-based":[51,208],"chemotherapy":[52,97,163,209,295],"can":[53,289],"alleviate":[54],"such":[55],"immunosuppression,":[56],"potentially":[57],"creating":[58],"a":[59,70,195,333],"window":[60],"opportunity":[62],"for":[63,157,203,313,337],"cell-based":[65],"immunotherapy.":[66],"METHODS:":[67],"We":[68],"initiated":[69],"phase":[71],"I/II":[72],"trial":[73],"(NCT04072263)":[74],"patients":[76,149,184,191,315],"recurrent":[78],"platinum-sensitive":[79],"receiving":[81],"TIL":[82,113,152,160,197,287,321],"during":[83,162,323],"platinum-based":[84,294,324],"chemotherapy.":[85],"TILs":[86],"were":[87,100,142,150,200,236],"administered":[88],"2":[89,180],"weeks":[90],"after":[91],"the":[92,122,132,170,176,259,308],"second,":[93],"third":[94],"fourth":[96],"course.":[98],"Patients":[99],"treated":[101],"two":[103,233,266,314],"cohorts":[104],"or":[106],"without":[107,164],"interferon-\u03b1":[108],"(IFNa),":[109],"as":[110,144,187,332],"conditioning":[111],"support":[114],"regimen.":[115],"primary":[117],"endpoint":[118],"was":[119,167,263],"evaluate":[121],"feasibility":[123],"safety":[125],"according":[126],"CTCAE":[128],"V.4.03":[129],"criteria":[130],"response":[134,242],"immune":[136,284],"modulatory":[137],"effects":[138],"this":[140],"treatment":[141,161,193,335],"evaluated":[143,202],"secondary":[145],"endpoints.":[146],"RESULTS:":[147],"Sixteen":[148],"enrolled.":[151],"could":[153],"successfully":[155],"expanded":[156],"all":[158],"patients.":[159,339],"IFNa":[165,173],"(n=13)":[166],"safe":[168],"but":[169,296],"combination":[171,299],"added":[174],"chemotherapy-induced":[177],"toxicity":[178],"out":[181],"3":[183],"developing":[185],"thrombocytopenia":[186],"dose-limiting":[188],"toxicity.":[189],"Fourteen":[190],"completed":[192],"full":[196],"cycle":[198],"further":[201,317,327],"immunological":[206],"response.":[207],"resulted":[210],"reduction":[212,304],"circulating":[214],"numbers":[217],"IL-6":[219],"plasma":[220],"levels,":[221],"confirming":[222],"its":[223],"immunosuppression-alleviating":[224],"effect.":[225],"Three":[226],"complete":[227],"(CR),":[228],"nine":[229],"partial":[230],"responses":[231],"stable":[234],"diseases":[235],"recorded,":[237],"resulting":[238],"an":[240,269],"objective":[241],"rate":[243],"86%":[245],"(Response":[246],"Evaluation":[247],"Criteria":[248],"In":[249],"Solid":[250],"Tumors":[251],"V.1.1).":[252],"Interestingly,":[253],"progression":[254],"free":[255],"survival":[256],"exceeded":[258],"previous":[260],"platinum-free":[261,311],"interval":[262,312],"detected":[264],"patients,":[267],"including":[268],"exceptionally":[270],"long":[271],"ongoing":[273],"CR":[274],"one":[276],"patient":[277],"coincided":[279],"sustained":[281],"alleviation":[282],"suppression.":[285],"CONCLUSION:":[286],"safely":[291],"combined":[292],"not":[297],"IFNa.":[301],"chemotherapy-mediated":[303],"increase":[309],"warrants":[316],"exploration":[318],"properly-timed":[320],"infusions":[322],"chemotherapy,":[325],"possibly":[326],"benefiting":[328],"from":[329],"IL-2":[330],"support,":[331],"novel":[334],"option":[336]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-11-11T00:00:00"}
